Literature DB >> 11758756

Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.

G L Li1, M Danhof, J A Bouwstra.   

Abstract

PURPOSE: To examine the mechanisms of transdermal iontophoretic delivery of apomorphine.
METHODS: Anodal iontophoresis of R-apomorphine across human stratum corneum was determined in vitro. The effects on the flux of the following parameters were studied: stability of drug, pH of donor solution, concentration of NaCl, and type of Na+ co-ions.
RESULTS: Ascorbic acid was effective to prevent apomorphine degradation. The iontophoretic transport of apomorphine was strongly influenced by the pH of the donor formulation. Increasing the pH from 3 to 6 resulted in an increase in the iontophoretic apomorphine flux from 27.9+/-4.4 nmol/cm2*h to 78.2+/-6.9 nmol/cm2*h. Upon decreasing NaCl concentration from 8 to 2 g/L, the iontophoretic flux was not significantly changed. Replacing NaCl in the donor formulation by tetraethylammonium chloride or tetrabutylammonium chloride resulted in 1.3 fold greater steady-state flux.
CONCLUSIONS: For optimized apomorphine iontophoretic delivery, a constant pH of the donor formulation is of great importance. The results suggest that although flux enhancement during iontophoresis is largely due to the electrical potential gradient, secondary effects, such as convective flow and electroosmosis may also contribute.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11758756     DOI: 10.1023/a:1013014010921

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

Review 1.  Clinical usefulness of apomorphine in movement disorders.

Authors:  C Colosimo; M Merello; A Albanese
Journal:  Clin Neuropharmacol       Date:  1994-06       Impact factor: 1.592

2.  Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

3.  Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

4.  The effect of iontophoresis and vehicle pH on the in-vitro permeation of lignocaine through human stratum corneum.

Authors:  O Siddiqui; M S Roberts; A E Polack
Journal:  J Pharm Pharmacol       Date:  1985-10       Impact factor: 3.765

5.  Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.

Authors:  R van der Geest; T van Laar; J M Gubbens-Stibbe; H E Boddé; M Danhof
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

6.  Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.

Authors:  R van der Geest; M Danhof; H E Boddé
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

7.  Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis).

Authors:  L P Gangarosa; N H Park; C A Wiggins; J M Hill
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

Review 8.  Apomorphine in patients with Parkinson's disease.

Authors:  D Muguet; E Broussolle; G Chazot
Journal:  Biomed Pharmacother       Date:  1995       Impact factor: 6.529

9.  Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer.

Authors:  L Wearley; Y W Chien
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

  9 in total
  1 in total

1.  Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.

Authors:  Akhmad Kharis Nugroho; Gai Ling Li; Meindert Danhof; Joke A Bouwstra
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.